The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E

Journal of Molecular Biology

Volumn 312, Issue 4, 2001, Pages 609-623

  Kentsis, Alex ^a   Dwyer, Elizabeth Campbell ^a   Perez, Jacqueline M ^a   Sharma, Madhulika ^a   Chen, Angus ^a   Pan, Zheng Q ^a   Borden, Katherine L B ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

eIF4E; PML; RING; Translation; Z

Indexed keywords

ARENAVIRUS PROTEIN Z; GUANOSINE DERIVATIVE; INITIATION FACTOR 4E; MESSENGER RNA; PROMYELOCYTIC LEUKEMIA PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ARENAVIRUS; ARTICLE; BINDING AFFINITY; HUMAN; HUMAN CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TRANSLATION INITIATION; VIRUS INFECTION; VIRUS PATHOGENESIS;

ARENAVIRUS; MAMMALIA;

EID: 0035965139     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.5003     Document Type: Article

References (47)

1. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
2. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia
3. The t(15;17) translocation alters a nuclear body in a retinoic acid- reversible fashion
4. A novel macromolecular structure is a target of the promyelocyte- retinoic acid receptor oncoprotein
5. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: Immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia
6. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms
7. PML, a growth suppressor disrupted in acute promyelocytic leukemia
8. Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues
9. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein
10. The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0
11. Dynamic redistribution of nuclear matrix proteins by adenovirus infection
12. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm
13. Construction of macromolecular assemblages in eukaryotic processes and their role in human disease: Linking RINGs together
14. RING domains: Master builders of molecular scaffolds?
15. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML
16. In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML
17. Two RING finger proteins, the oncoprotein PML and the arena-virus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins
18. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA
19. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner
20. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA
21. Complex formation by the Drosophila MSL proteins: Role of the MSL2 RING finger in protein complex assembly
22. Cocrystal structure of the messenger RNA 5′ cap-binding protein (eIF4E) bound to 7-methyl-GDP
23. eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation
24. RING finger proteins: Mediators of ubiquitin ligase activity
25. The conserved RING-H2 finger of ROC1 is required for ubiquitin ligation
26. Cb1-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3- kinase for ubiquitination in T cells
27. Structure of translation factor eIF4E bound to m7GDP and interaction with 4E-binding protein
28. A spectroscopic study of the binding of N-7-substituted cap analogues to human protein synthesis initiation factor 4E
29. A spectroscopic study of the binding of m7GTP and m7GpppG to human protein synthesis initiation factor 4E
30. Stabilisation of eukaryotic initiation factor 4E-binding to the mRNA 5′-cap by domains of eIF4G
31. The mRNA 5′ cap-binding protein eIF4E and control of cell growth
32. Cooperative modulation by eIF4G of eIF4E-binding to the mRNA 5′ cap in yeast involves a site partially shared by p20
33. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state
34. The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain
35. Arenaviruses
36. The broad spectrum antiviral agent ribavirin inhibits capping of mRNA
37. Antiviral agents: Characteristic activity spectrum depending on the molecular target with which they interact
38. Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NB4- R2
39. The translation initiation factor eIF3-p48 subunit is encoded by int-6, a site of frequent integration by the mouse mammary tumor virus genome
40. Coupled transcription and translation within nuclei of mammalian cells
41. Reconstitution of the KRAB-KAP-1 repressor complex: A model system for defining the molecular anatomy of RING-B box-coiled-coil domain- mediated protein-protein interactions
42. Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5′ End
43. Ubiquitin and the control of protein fate in the secretory and endocytic pathways
44. Does this have a familiar RING?